{
    "2020-10-28": [
        [
            {
                "time": "",
                "original_text": "天坛生物拟定增33亿“补血”产能翻倍 4.9亿用于血友病新药研制相关项目",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "定增",
                        "补血",
                        "产能翻倍",
                        "血友病",
                        "新药研制"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海莱士（002252.SZ）：前三季度净利升80.80%至10.96亿元",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "净利",
                        "增长",
                        "80.80%",
                        "前三季"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士（002252.SZ）控股股东莱士中国被动减持555.3万股 减持股份",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "控股股东",
                        "莱士中国",
                        "被动减持",
                        "555.3万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士（002252.SZ）控股股东科瑞天诚被动减持2720万股 减持股份",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "控股股东",
                        "科瑞天诚",
                        "被动减持",
                        "2720万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士（002252.SZ）第三季度归母净利润同比增长106.71%至3.99亿元",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "归母净利润",
                        "增长",
                        "106.71%",
                        "第三季度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士：第三季净利同比增长106.71%",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "净利",
                        "增长",
                        "106.71%",
                        "第三季"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士：前三季度净利润同比增长80.8%",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "净利润",
                        "增长",
                        "80.8%",
                        "前三季"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}